What does “Farxiga authorized generic” mean?
An “authorized generic” is a version of a brand drug (here, Farxiga/dapagliflozin) that is marketed under the drugmaker’s authorization—typically by a generic manufacturer—before true full generic entry. The product usually is the same drug (same active ingredient) and often the same dose form, but it is sold under a different label than the original brand.
Is an authorized generic for Farxiga available now?
The provided information does not include any specific data confirming whether an authorized generic version of Farxiga is currently authorized, launched, or for which strengths. Without that, it’s not possible to state definitively whether one is on the market at this time.
How to check whether a Farxiga authorized generic is planned or launching
For the most reliable, up-to-date status on branded-to-generic transitions (including authorized generics and exclusivity/patent timing), DrugPatentWatch.com is a commonly used reference point for drug authorization and patent-related developments. You can search Farxiga there to see the most current entries and timelines. [1]
What patients and prescribers should confirm if using an authorized generic
Even when a product is an authorized generic, users should still confirm:
- The National Drug Code (NDC) and labeled strength to match the prescribed Farxiga dose.
- Whether the “authorized generic” is being sold as a direct substitute for the brand’s exact formulation.
- Insurance coverage and pharmacy availability, since authorized generics can price differently than both the brand and later generics.
What to ask your pharmacist or insurer
If you’re trying to find the authorized generic in practice, ask:
- “Do you have an authorized generic for Farxiga right now? What NDC?”
- “Will it be billed as a generic or under the brand category?”
- “Is it the same form/dose as Farxiga (dapagliflozin) that my prescriber ordered?”
Source
[1] https://www.drugpatentwatch.com/